Subscribe to our mailing list

Sufferers die as Gilead’s breakthrough most cancers drug reaches only some

Two months after Gilead Sciences’ breakthrough therapy was authorized within the U.S. to deal with a lethal type of blood most cancers, solely a tiny handful of sufferers have really gotten the pricey remedy, whereas others linger on ready lists.

5 folks have obtained the therapy, referred to as Yescarta, on the 15 most cancers hospitals approved to manage it within the U.S., the hospitals stated. Ready lists for the $373,000 therapy have grown to at the very least 200 folks, shrinking solely as some very sick sufferers have died.

Medical doctors on the most cancers facilities blame holdups in getting the therapy paid for by Medicare and Medicaid, in addition to a number of the U.S.’s largest insurers.

Powered by WPeMatico

Author: Techno Info

VN:F [1.9.22_1171]
Rating: 0.0/10 (0 votes cast)
VN:F [1.9.22_1171]
Rating: 0 (from 0 votes)

Author Spotlight